Bilaketaren emaitzak - Amanda Farrugia

  • Erakusten 1 - 5 emaitzak -- 5
Findu emaitzak
  1. 1
    The Nitrogen-Containing Bisphosphonate, Zoledronic Acid, Influences RANKL Expression in Human Osteoblast-Like Cells by Activating TNF-α Converting Enzyme (TACE)

    The Nitrogen-Containing Bisphosphonate, Zoledronic Acid, Influences RANKL Expression in Human Osteoblast-Like Cells by Activating TNF-α Converting Enzyme (TACE) nork Bei-Qing Pan, Amanda Farrugia, Luen Bik To, David M. Findlay, Jonathan Green, Kevin Lynch, Andrew C.W. Zannettino

    Argitaratua 2004
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Imatinib as a potential antiresorptive therapy for bone disease

    Imatinib as a potential antiresorptive therapy for bone disease nork Andrea L. Dewar, Amanda Farrugia, Mark R. Condina, Luen Bik To, Timothy P. Hughes, B. Vernon‐Roberts, Andrew C.W. Zannettino

    Argitaratua 2006
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    RANK Expression as a Cell Surface Marker of Human Osteoclast Precursors in Peripheral Blood, Bone Marrow, and Giant Cell Tumors of Bone

    RANK Expression as a Cell Surface Marker of Human Osteoclast Precursors in Peripheral Blood, Bone Marrow, and Giant Cell Tumors of Bone nork Gerald J. Atkins, P. Kostakis, C. Vincent, Amanda Farrugia, Jeffrey P. Houchins, David M. Findlay, Andreas Evdokiou, Andrew C.W. Zannettino

    Argitaratua 2006
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Targeted Disruption of the CXCL12/CXCR4 Axis Inhibits Osteolysis in a Murine Model of Myeloma-Associated Bone Loss

    Targeted Disruption of the CXCL12/CXCR4 Axis Inhibits Osteolysis in a Murine Model of Myeloma-Associated Bone Loss nork Peter Diamond, Agatha Labrinidis, Sally K. Martin, Amanda Farrugia, Stan Gronthos, Luen Bik To, Nobutaka Fujii, Peter D. O’Loughlin, Andreas Evdokiou, Andrew C.W. Zannettino

    Argitaratua 2009
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Elevated Serum Levels of Stromal-Derived Factor-1α Are Associated with Increased Osteoclast Activity and Osteolytic Bone Disease in Multiple Myeloma Patients

    Elevated Serum Levels of Stromal-Derived Factor-1α Are Associated with Increased Osteoclast Activity and Osteolytic Bone Disease in Multiple Myeloma Patients nork Andrew C.W. Zannettino, Amanda Farrugia, Angela Kortesidis, Jim Manavis, Luen Bik To, Sally K. Martin, Peter Diamond, Hirokazu Tamamura, Tsvee Lapidot, Nobutaka Fujii, Stan Gronthos

    Argitaratua 2005
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: